Schwab Health Care
(MUTF:SWHFX) Watch this mutual fundFind more results for
SWHFX
Performance
Trailing returns
| 1 day |
| -0.55% | |||
| 1 week |
| -1.29% | |||
| 4 week |
| -0.96% | |||
| 3 month | +9.04% |
| |||
| YTD |
| -0.96% | |||
| 1 year | +21.15% |
| |||
| 3 years* |
| -1.73% | |||
| 5 years* | +3.99% |
| |||
| *annualized | |||||
| Best 3 month return | +19.45% | |
| Worst 3 month return | -25.16% |
Morningstar statistics
Morningstar category: Health
| Return | Risk | Rating | |
| 3 years | - | - |
 
|
| 5 years | - | - |
|
| 10 years | - | - | - |
| Overall | - | - |
|
Morningstar style Learn more
| Large | |||
| Mid | |||
| Small | |||
| Value | Blend | Growth |
Key statistics
| Total assets | 440.36M | |
| Front load | - | |
| Deferred load | - | |
| Expense ratio | 0.82% | |
| Management fee | - | |
| Fund family | Schwab Funds |
Asset allocation
| Cash | 2.43% | |
| Stocks | 97.40% | |
| Bonds | 0.00% | |
| Other | 0.17% |
Purchase information
| Initial | $100 | |
| Additional | $0 |
14.35
+0.12 (0.84%)
Feb 9, 8:00PM EST
Overall Morningstar RatingTM
Description
The investment seeks long-term capital growth.
The fund invests at least 80% of net assets in equity securities issued by companies in the health care sector. It may also invest in futures contracts. The fund primarily invests in U.S. companies, but may invest up to 25% of net assets in the stocks of publicly traded companies located in countries other than the United States. It uses Schwab Equity Ratings to aid its stock selection. The fund is nondiversified.
Fund filings (PDF) »
Fund filings (PDF) »
Asset managers:
Paul Davis (Started: Jun 15, 2006)
Eric Thaller (Started: Feb 28, 2009)
Vivienne Hsu (Started: Sep 30, 2004)
Larry Mano (Started: Jul 3, 2000)
Jeffrey Mortimer (Started: Jul 19, 2004)
Paul Davis (Started: Jun 15, 2006)
Eric Thaller (Started: Feb 28, 2009)
Vivienne Hsu (Started: Sep 30, 2004)
Larry Mano (Started: Jul 3, 2000)
Jeffrey Mortimer (Started: Jul 19, 2004)
Risk
| 1 year | 3 years | 5 years | 10 years | ||
| Alpha* | -1.39 | 3.10 | 3.02 | - | |
| Beta* | 0.72 | 0.72 | 0.71 | - | |
| Mean annual return | 1.73 | -0.02 | 0.41 | - | |
| R-squared* | 70.00 | 70.69 | 65.49 | - | |
| Standard deviation | 17.28 | 17.06 | 14.09 | - | |
| Sharpe ratio | 1.19 | -0.13 | 0.14 | - | |
| * Against standard index | |||||
Top 10 holdings
| Security | Net Assets | |
| Pfizer Inc. (PFE) | 5.46% | |
| Johnson & Johnson (JNJ) | 5.40% | |
| Amgen, Inc. (AMGN) | 4.61% | |
| Merck & Co., Inc. (MRK) | 4.07% | |
| Abbott Laboratories (ABT) | 3.47% | |
| Baxter International Inc. (BAX) | 2.78% | |
| Bristol-Myers Squibb Company (BMY) | 2.74% | |
| Express Scripts (ESRX) | 2.38% | |
| Roche Holding AG (RHHVF) | 2.36% | |
| McKesson, Inc. (MCK) | 2.35% |